The SARS-CoV-2 coronavirus presents major challenges to healthcare systems and medical facilities worldwide. The rapid diagnosis makes an important contribution to curbing the rapid spread of coronavirus in many countries including Germany.
ArminLabs is one of the leading Laboratories regarding the diagnosis of chronic and acute infections and has implemented in record time the gold standard of diagnosis of SARS-CoV-2.
Nucleic Acid Amplification Technique tests are currently the most reliable COVID 19 tests for diagnosing infections with the new coronavirus SARS-CoV-2. This includes the PCR method (Polymerase Chain Reaction, PCR), which can be used to directly detect the SARS-CoV-2 virus in infected persons on the basis of a throat swab, nose swab, and throat lavage.
If you're interested in receiving our special blood-collection testkits, please write us an Email to firstname.lastname@example.org or give us a call.
Patients or therapists from the UK can contact email@example.com.
The COVID-19 Symptomchecklist is a supportive tool in the clinical diagnosis of the practitioner/therapist.
It does not replace a detailed clinical diagnosis.
All testing for COVID-19 should be conducted in consultation with a healthcare provider. Also, they are able to collect the specimens once a clinical determination has been made to pursue COVID-19 testing.
For initial diagnostic testing for COVID-19, WHO and CDC recommends collecting and testing an upper respiratory specimen. The nasopharyngeal specimen is the preferred choice for swab-based SARS-CoV-2 testing, this means throat swab (swab the posterior pharynx, avoiding the tongue), and nasopharyngeal swab. When the collection of a nasopharyngeal swab is not possible, ArminLabs has established an acceptable alternative. Since in the throat and in the sputum a high concentration of viable SARS-CoV-2 viruses can be found within the first week after the first symptoms appear, ArminLabs offers the RT-PCR also from throat lavage.
Info provided from WHO, RKI, CDC, Wölfel R et al. Virological assessment of hospitalized patients with COVID-2019. Nature (2020). doi: 10.1038/s41586-020-2196-x and open sources